Boy dies after being administrated wrong injection by ‘ fake doctor ‘ in TN

VANIYAMBADI: A 13-year-old boy who was administrated an injection for fever by a ‘quack’ in Thirupattur’s Vaniyambadi died within a few hours after he experienced severe stomach pain.

The Vaniyambadi town police arrested the fake doctor, Gopinath of the Thoppalagunda area, on Wednesday based on a complaint from the boy’s family.

Police said the boy, C Surya Prakash was a class seven student, a resident of Thoppalagunda in Vaniyambadi.

Surya Prakash developed a fever on Tuesday and was taken to see a doctor, Gopinath who was practising medicine at his house in the locality.  On July 4, Gopinath administered an injection to Surya Prakash. A few minutes after reaching the house, the boy began experiencing stomach pain, fever and collapsed.

The boy was rushed to the Natrampalli town hospital, where doctors declared him brought dead.

Based on a complaint from the family, Thimmampettai police registered a case and began an investigation. After an inquiry, the police found Gopinath was not a qualified medical practitioner but has been prescribing tablets and administering injections. He was arrested by the police.

The district health department has ordered a probe into the incident. The department also warned of strict action against ‘ doctors’ using fake or unapproved degrees to advertise and practise.

A medical officer said the department has issued guidelines for all doctors in the state, asking them to register with the council, and displaying of basic medical degree as MBBS  and not MD to avoid confusion among people.

Related Posts

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid